Integra LifeSciences Holdings Co (NASDAQ: IART) has reported a loss for its third fiscal quarter (ending September 30) of $-0.14 versus $0.24 for the same period a year ago — a decline of -158%. For the latest four quarters through September 30, E.P.S. were $-0.08 versus $1.23 for the same period a year ago — a decline of -107%.
Recent Price Action
Integra LifeSciences Holdings Co (NASDAQ: IART) stock enjoyed a major increase of 25.1% on 11/4/24. The shares closed at $24.12. Moreover, this advance was accompanied by exceptionally high trading volume at 393% of normal. The stock has risen 27.3% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, IART is expected to continue to be an important Value Builder.
Integra LifeSciences Holdings has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Integra LifeSciences Holdings has a good Appreciation Score of 80 but a very low Power Rating of 10, leading to the Low Neutral Value Trend Rating.
Rating Review
In light of this new information and very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment